Posts

Showing posts from April, 2026

ICSR Case Challenge #2: Serious vs Non-Serious (Case Scenarios + Interview-Level Thinking)

  πŸ§ͺ ICSR Case Challenge #2: Serious vs Non-Serious (Case Scenarios + Interview-Level Thinking) πŸ“’ From Theory → Real Pharmacovigilance Decision-Making After understanding how to identify a valid ICSR , the next critical step in pharmacovigilance is: πŸ‘‰ Determining whether a case is Serious or Non-Serious This is not just a theoretical concept—it directly impacts: Regulatory reporting timelines Case processing priority Compliance with global pharmacovigilance guidelines If you are preparing for pharmacovigilance roles, this is one of the most frequently tested and commonly misunderstood topics . πŸ“Œ Before You Start If you're new or want to strengthen your basics, review these first: πŸ‘‰  ICSR Case Processing   πŸ‘‰ PV Terminologies πŸ‘‰ Seriousness Vs Severity  These will help you connect theory with the case-based thinking below. πŸ’‘ Serious vs Severity: The Most Common Confusion Let’s address the biggest mistake beginners make: ❌ “Severe symptoms = Serious case” πŸ‘‰ This...